Founders / Clarissa Desjardins
Clarissa Desjardins
Clarissa Desjardins is the co-founder and CEO of Congruence Therapeutics, a health and biotech AI company based in Montréal. Congruence Therapeutics had raised US$71.5M across 2 rounds as of November 2026, most recently a US$39.5M venture round in March 2026 led by Dimension and OrbiMed.
Co-founder/CEO of Congruence Therapeutics.
Congruence Therapeutics
Computationally driven drug discovery using its Revenir platform (biophysics and machine learning) to design small-molecule correctors for protein-misfolding diseases.
- Role
- Co-founder/CEO
- HQ
- Montréal, QC
- Founded
- 2021
- Status
- Active
- Disclosed raised
- US$71.5M
- Latest round
- Venture round, Mar 19, 2026
- Website
- congruencetx.com
Investors: Dimension, OrbiMed, Amplitude Ventures, Fonds de solidarité FTQ, Lumira Ventures, Investissement Québec, BDC Thrive Venture Fund, Driehaus Capital Management, and 2 more
Founders are listed as named in primary coverage of their companies. Profile links are matched to the company before they are published. To correct this page or ask for it to be removed, email the Index.
Data as of November 10, 2026.